Key result
A polygenic lifespan score was associated with all-cause mortality and major noncommunicable diseases, with time-dependent hazard ratios ranging from approximately 0.70 to 1.20.
Why the study?
Aging increases the risk of major noncommunicable diseases, and the extent to which a genetic predisposition for a long lifespan is associated with all-cause mortality and major age-related diseases required investigation.
Does a polygenic lifespan score predict the risk of all-cause mortality and major age-related noncommunicable diseases?
Observational (n=376,753)
Does a polygenic lifespan score predict the risk of all-cause mortality and major age-related noncommunicable diseases?
Effect estimate: HR ≈0.70 to ≈1.20
A genetic predisposition for a longer lifespan is associated with a modestly reduced risk of common age-related noncommunicable diseases and mortality.
Small effect sizes preclude using lifespan polygenic scores for clinical risk prediction; leaves open environmental modifiers of genetic longevity.
BACKGROUND: Aging increases the risk of major noncommunicable diseases. Research into the genetics of health-related traits could reveal genetic pathways for robustness against these diseases. We studied how a genetic predisposition for a long lifespan is associated with the risk of all-cause mortality and major age-related noncommunicable diseases. METHODS: We analyzed data from 376 753 participants (mean age = 58.5 years; standard deviation = 13.9 years; 46.3% men) to examine how a polygenic lifespan score (PLS) is associated with the risk of all-cause mortality and major noncommunicable diseases. The associations between all-cause mortality, cancers, femur fracture, dementia, Alzheimer's disease, Parkinson's disease, type 2 diabetes, obesity, cardiovascular diseases, hypertension, ischemic heart diseases, coronary heart disease, stroke, and myocardial infarction were investigated using conventional and time-dependent Cox regression. RESULTS: The PLS was associated with all the above-mentioned outcomes except for Parkinson's disease. Most of the associations were time-dependent, and the hazard ratio (HR) varied over time from protective to risk-increasing. However, the current PLS predicted noncommunicable disease risks with small effect sizes (lowest HR ≈ 0.70, highest HR ≈ 1.20, Cox-Snell pseudo-R2 > 0.01). CONCLUSIONS: Genetic predisposition for a longer lifespan was associated with a smaller risk of common age-related noncommunicable diseases, suggesting greater robustness against these conditions. The lowest risks were found during periods when the incidences of diseases were greatest. The observed small effects highlight the need to better understand how accumulated environmental factors modify individual lifespans.
No takes yet. Share an insight, caveat, or question.
Tynkkynen et al. (2025) conducted an observational in Age-related noncommunicable diseases and mortality (n=376,753). Polygenic lifespan score (PLS) was evaluated on All-cause mortality and major noncommunicable diseases (HR ≈0.70 to ≈1.20). A polygenic lifespan score was associated with all-cause mortality and major noncommunicable diseases, with time-dependent hazard ratios ranging from approximately 0.70 to 1.20.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: